Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
PremiumPress ReleasesGrifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
26d ago
Grifols highlights ‘strong liquidity position’ after credit downgrade
PremiumThe Fly
Grifols highlights ‘strong liquidity position’ after credit downgrade
1M ago
Grifols falls 7% after Moody’s downgrades credit rating
PremiumThe Fly
Grifols falls 7% after Moody’s downgrades credit rating
1M ago
Grifols receives FDA approval for Yimmugo
PremiumThe FlyGrifols receives FDA approval for Yimmugo
1M ago
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin  to treat primary immunodeficiencies
PremiumPress Releases
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
1M ago
Grifols says on track to meet guidance for 2024
PremiumThe Fly
Grifols says on track to meet guidance for 2024
2M ago
Grifols says on track to close Haier strategic alliance in first half of 2024
PremiumThe FlyGrifols says on track to close Haier strategic alliance in first half of 2024
3M ago
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
PremiumPress Releases
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
3M ago
Grifols announces commencement of refinancing process
PremiumThe Fly
Grifols announces commencement of refinancing process
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100